Table 2.
Participant demographics
| Group (n) | Stroke (14) | Healthy controls (17) | All healthy (85) |
|---|---|---|---|
| Age (years) | 74.5 (61.3–83.3) | 76.00 (74.5–81.5) | 49.00 (29.0–70.0) |
| Sex | |||
| Male | 9 | 10 | 42 |
| Female | 5 | 7 | 43 |
| Barthel | 4.0 *(0.0–10.8) | 20.0 (20.0–20.0) | 20.00 (20.0–20.0) |
| Stroke type |
R MCA infarct (5) L MCA infarct (3) L PICA infarct (1) L pontine infarct (1) R thalamic haemorrhage (1) R parietal haemorrhage (1) Multiple posterior circulatory infarcts (1) Multiple scattered lacunar infarcts (1) |
n/a | n/a |
| Days from stroke to session 1 | 16.5 (7.0–1.3) | n/a | n/a |
| PAS on FEES | 7.5 (5.3–8.0) | n/a | n/a |
| FOIS | 4.0* (1.0–5.0) | 7.0 (7.0–7.0) | 7.00 (7.0–7.0) |
| Days between sessions | 3.00 (1.0–4.0) | 5.00 (1.5–7.0) | 6.0 (4.0–7.0) |
PAS penetration aspiration scale, FOIS functional oral intake
Medians and interquartile ranges are shown. Significant differences between the stroke group and both healthy groups are indicated by * (p ≤ 0.001) on Mann–Whitney U Test for independent samples